Quest Diagnostics Q1 EPS $3.76 Beats $3.71 Estimate, Sales $2.72B Beat $2.64B Estimate

Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $3.76 per share which beat the analyst consensus estimate of $3.71 by 1.35 percent. This is a 300 percent increase over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $2.72 billion which beat the analyst consensus estimate of $2.64 billion by 3.03 percent. This is a 49.29 percent increase over sales of $1.82 billion the same period last year.